Dr. Priyatham S. Mettu, MD

  • Durham, NC
  • Ophthalmologist
NPI1508023284PAC ID4082765995
Medicare services, 2024
6,691
Medicare patients, 2024
793
Part D claims, 2024
268
Publications
26
Clinical trials
3
Practice address
2301 Erwin Rd, Durham, NC 27705
Practice phone
Call (919) 684-8111
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Duke University Hospital

Hospital · Durham, North Carolina

See all 6 affiliations

Find Dr. Mettu's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Priyatham S. Mettu is an ophthalmologist in Durham, North Carolina

Dr. Mettu practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Mettu's NPI, 1508023284, was assigned on May 20, 2008. Dr. Mettu graduated from Duke University School of Medicine in 2005. Dr. Mettu holds North Carolina license 2009-00557.

NPI and contact details
Medicare PAC ID
4082765995
NPI enumeration date
May 20, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(919) 684-8111
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Priyatham S. Mettu practices at Duke University Hospital in Durham, North Carolina

Dr. Mettu's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Source: Dmand AI Affiliation Data

Dr. Priyatham S. Mettu is affiliated with 5 sites of care and 1 medical group

Dr. Mettu's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Mettu is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Mettu to 2 more hospitals and 1 group practice or clinic, each named with a free account.

See all 6 affiliations for Dr. Mettu

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Priyatham S. Mettu's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mettu practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Duke University HospitalAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mettu practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Duke University and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Priyatham S. Mettu is one of 552 ophthalmologists in North Carolina

Ophthalmology is Dr. Mettu's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mettu is licensed in North Carolina.

Specialties and state licenses

  • Ophthalmology, North CarolinaPrimaryLicense 2009-00557 · taxonomy 207W00000X

Ophthalmologists near Dr. Mettu

Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Priyatham S. Mettu billed Medicare for 6,691 services in 2024

CMS data shows 6,691 Medicare services from Dr. Mettu across 15 procedure codes in 2024, for 793 Medicare patients. Medicare paid $340,909 for them.

Medicare services, 20246,691
Medicare patients793
Paid by Medicare$340,909
Procedure codes15

Dr. Mettu's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Tests and treatments
2023: 4,3782024: 4,91612%
Surgery
2023: 1,6692024: 1,669No change
Other services
2023: 02024: 78
Imaging
2023: 402024: 2830%

Where Dr. Mettu's Medicare services took place, 2024

  • In an office5,02275%
  • In a facility1,66925%

Dr. Mettu compared with the North Carolina median for ophthalmologists, 2024

  • Dr. Mettu
  • North Carolina median
Medicare services
6,691vs 1,7013.9 times
Medicare patients
793vs 56640% above
Part D claims
220vs 62065% below

Medians across 580 ophthalmologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Mettu's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mettu

Need commercial claims for Dr. Mettu?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mettu and other ophthalmologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Priyatham S. Mettu treated 793 Medicare patients in 2024, average age 78

CMS counts 793 Medicare patients who saw Dr. Mettu in 2024. The largest group is 75 to 84, with 330 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mettu's median patient age at 79, with 61% women.

Medicare patients, 2024793
Average age78
Average risk score1.53
Also on Medicaid6%

Dr. Mettu's Medicare patients by age, 2024

Dr. Mettu's Medicare patients by sex, 2024

  • Women48461%
  • Men30939%

Chronic conditions among Dr. Mettu's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol74%
  3. Arthritis50%
  4. Diabetes38%
  5. Chronic kidney disease30%
  6. Ischemic heart disease30%
  7. Osteoporosis22%
  8. Atrial fibrillation21%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mettu's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 79

Patient panel by sex, all payers

  • Women61%
  • Men38%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Priyatham S. Mettu wrote 268 Medicare Part D claims in 2024

In 2024, Dr. Mettu wrote 268 Medicare Part D claims for 81 patients. 69% of them were for generic drugs. CMS names the drug for 220 of them, across 5 drugs with 11 or more claims each, at $4,323 in total drug cost. In 2023, CMS named 184 claims across 5 drugs.

Part D claims, 2024268
Drugs named by CMS5
Total drug cost$4,323
Part D patients81

Dr. Mettu's Part D claims by kind of drug, 2024

  • Generic184 claims69%
  • Brand-name84 claims31%

Dr. Mettu's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1842024: 22020%

Drugs named by CMS: 5 in 2024, 5 in 2023.

See all prescribing by Dr. Mettu

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Priyatham S. Mettu takes part in Medicare

Dr. Mettu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find ophthalmologists like Dr. Mettu by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Priyatham S. Mettu has 26 publications on record

Dmand AI links 26 papers to Dr. Mettu, published from 2012 to 2025. 2012 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Macular Degeneration and Fluorescein Angiography. Dr. Mettu has published most often in Invest Ophthalmol Vis Sci. Dr. Mettu's most frequent co-authors are Michael John Allingham, MD, PhD, Cynthia A. Toth, MD and Pratap Challa, MD.

Papers26
Years published2012 to 2025

Dr. Mettu's papers by year, 2012 to 2025

Topics Dr. Mettu writes about most

  • Tomography, Optical Coherence
  • Macular Degeneration
  • Fluorescein Angiography
  • Aldosterone
  • Algorithms
  • Blotting, Western
  • Choroidal Neovascularization
  • Disease Models, Animal

Dr. Mettu's most frequent co-authors

Recent publications by Dr. Mettu

See all 26 publications and co-authors

See who Dr. Mettu researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mettu works with, so you can find a warm path to the right ophthalmologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Priyatham S. Mettu has worked on 3 clinical trials

Dmand AI links Dr. Mettu to 3 clinical trials. Conditions studied include Diabetic Retinopathy, Macular Degeneration and Retinal Vein Occlusion. Duke University sponsors the most, 3.

Conditions in Dr. Mettu's trials

  • Diabetic Retinopathy
  • Macular Degeneration
  • Retinal Vein Occlusion
  • Diabetic Angiopathies
  • Retinal Degeneration

Investigators on the most trials with Dr. Mettu

Recent clinical trials with Dr. Mettu

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Priyatham S. Mettu received $112,092 in industry payments from 2017 to 2025

CMS Open Payments shows 62 general payments to Dr. Mettu from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 92% of the total. Astellas Pharma Global Development paid the most, $94,300. It also lists 1 research payment totaling $4,100 in 2023.

General payments to Dr. Mettu by program year, 2017 to 2025

General payments to Dr. Mettu by kind, 2017 to 2025

$112.1Kin total
  • Consulting fees$103,45092%
  • Honoraria$4,8004%
  • Food and beverage$2,7732%
  • Travel and lodging$6221%
  • Speaker and faculty fees$4470%

Companies that paid Dr. Mettu the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mettu

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Priyatham S. Mettu graduated from Duke University School of Medicine

Dr. Mettu graduated from Duke University School of Medicine in 2005.

  1. Medical schoolDuke University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Priyatham S. Mettu's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Priyatham S. Mettu

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Priyatham S. Mettu's NPI number?

Dr. Priyatham S. Mettu's NPI number is 1508023284. It was assigned on May 20, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Priyatham S. Mettu?

Dr. Priyatham S. Mettu is an ophthalmologist in Durham, North Carolina. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).

Where does Dr. Priyatham S. Mettu practice?

Dr. Mettu practices at 2301 Erwin Rd, Durham, NC 27705. Dr. Mettu's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dmand AI also links Dr. Mettu to 2 hospitals and 1 group practice or clinic.

What is Dr. Priyatham S. Mettu's office phone number?

The practice phone on file for Dr. Mettu is (919) 684-8111.

What is Dr. Priyatham S. Mettu's medical license number?

Dr. Mettu holds North Carolina license 2009-00557.

Which hospitals is Dr. Priyatham S. Mettu affiliated with?

Dr. Mettu practices at Duke University Hospital in Durham, North Carolina. Dr. Mettu is also affiliated with Duke Regional Hospital. Dmand AI links Dr. Mettu to 2 more hospitals.

What medical group is Dr. Priyatham S. Mettu part of?

Dr. Mettu is linked to Duke Health Integrated Practice.

Does Dr. Priyatham S. Mettu accept Medicare?

Yes. CMS data shows Dr. Mettu billed Medicare for 6,691 services in 2024, and Dr. Mettu accepts Medicare assignment.

How many Medicare patients does Dr. Priyatham S. Mettu see?

CMS counts 793 Medicare patients who saw Dr. Mettu in 2024, with an average age of 78.

What services does Dr. Priyatham S. Mettu bill to Medicare?

In 2024, Dr. Mettu's most billed Medicare services were eye exam or test (92134), surgery: eye (67028) and eye exam or test (92014).

Show 6 more questionsShow fewer questions

Where did Dr. Priyatham S. Mettu go to medical school?

Dr. Mettu graduated from Duke University School of Medicine in 2005.

What drugs does Dr. Priyatham S. Mettu prescribe most?

In 2024 Medicare Part D data, Dr. Mettu's most prescribed drugs by claims were Latanoprost, Dorzolamide-Timolol and Ketorolac Tromethamine.

Has Dr. Priyatham S. Mettu received payments from drug or device companies?

CMS Open Payments shows $112,092 in general payments to Dr. Mettu from 14 companies from 2017 to 2025. The largest total came from Astellas Pharma Global Development.

How long has Dr. Priyatham S. Mettu been practicing?

Dr. Mettu graduated from medical school in 2005, 21 years ago.

Does Dr. Priyatham S. Mettu do research?

Dmand AI links 26 publications to Dr. Mettu, published from 2012 to 2025. Dr. Mettu has worked on 3 clinical trials.

Who does Dr. Priyatham S. Mettu publish with?

Dr. Mettu's most frequent co-authors are Michael John Allingham, MD, PhD (9 shared papers), Cynthia A. Toth, MD (3 shared papers) and Pratap Challa, MD (2 shared papers).

Selling to ophthalmology practices?

See ophthalmologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)